The work of MUSC's Neuro-Oncology research and clinical teams was featured on the cover of the August Journal of Neuro-Oncology for their work in discovering the first direct evidence that the compound DATS, found in garlic, is effective in blocking pathways of the proliferation of cancer cells and ultimately may help reduce tumor growth in patients with glioblastoma, the most lethal brain tumor.

To learn more about this exciting research, please visit the MUSC Newsroom for a full article.